Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice.
Hanson BJ, Boon AC, Lim AP, Webb A, Ooi EE, Webby RJ
Respir Res 2006, 7:126
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Avian influenza virus (H5N1): a threat to human health.
Peiris JS, de Jong MD, Guan Y
Clin Microbiol Rev 2007 Apr, 20:243-67
 [PubMed Central] [PubMed] [Related articles]
2.
Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza.
Simmons CP, Bernasconi NL, Suguitan AL, Mills K, Ward JM, Chau NV, Hien TT, Sallusto F, Ha Q, Farrar J, de Jong MD, Lanzavecchia A, Subbarao K
PLoS Med 2007 May, 4:e178
 [PubMed Central] [PubMed] [Related articles]
3.
Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China.
Yu H, Gao Z, Feng Z, Shu Y, Xiang N, Zhou L, Huai Y, Feng L, Peng Z, Li Z, Xu C, Li J, Hu C, Li Q, Xu X, Liu X, Liu Z, Xu L, Chen Y, Luo H, Wei L, Zhang X, Xin J, Guo J, Wang Q, Yuan Z, Zhou L, Zhang K, Zhang W, Yang J, Zhong X, Xia S, Li L, Cheng J, Ma E, He P, Lee SS, Wang Y, Uyeki TM, Yang W
PLoS One 2008, 3:e2985
 [PubMed Central] [PubMed] [Related articles]
4.
Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.
Throsby M, van den Brink E, Jongeneelen M, Poon LL, Alard P, Cornelissen L, Bakker A, Cox F, van Deventer E, Guan Y, Cinatl J, ter Meulen J, Lasters I, Carsetti R, Peiris M, de Kruif J, Goudsmit J
PLoS One 2008, 3:e3942
 [PubMed Central] [PubMed] [Related articles]
5.
Monoclonal antibodies against the fusion peptide of hemagglutinin protect mice from lethal influenza A virus H5N1 infection.
Prabhu N, Prabakaran M, Ho HT, Velumani S, Qiang J, Goutama M, Kwang J
J Virol 2009 Mar, 83:2553-62
 [PubMed Central] [PubMed] [Related articles]
6.
Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.
Yoshida R, Igarashi M, Ozaki H, Kishida N, Tomabechi D, Kida H, Ito K, Takada A
PLoS Pathog 2009 Mar, 5:e1000350
 [PubMed Central] [PubMed] [Related articles]
7.
Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses.
Sun L, Lu X, Li C, Wang M, Liu Q, Li Z, Hu X, Li J, Liu F, Li Q, Belser JA, Hancock K, Shu Y, Katz JM, Liang M, Li D
PLoS One 2009, 4:e5476
 [PubMed Central] [PubMed] [Related articles]
8.
Combination therapy using chimeric monoclonal antibodies protects mice from lethal H5N1 infection and prevents formation of escape mutants.
Prabakaran M, Prabhu N, He F, Hongliang Q, Ho HT, Qiang J, Meng T, Goutama M, Kwang J
PLoS One 2009, 4:e5672
 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 2 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.